Introduction {#Sec1}
============

*Bacopa monniera* L. (Scrophulariaceae), commonly known as Brahmi, is a creeping plant with bitter taste found in marshy areas in India. It is used in the Indian system of ayurvedic medicine to enhance cognitive function. The leaf extract of *B. monniera* contains bioactive compounds bacosides A~1~--A~3~ \[[@CR1]--[@CR3]\], bacopasaponins A--G \[[@CR4]--[@CR7]\] and bacopasides I--V \[[@CR8], [@CR9]\]. A study claimed that bioactive compounds extracted from *B. monniera* improved acquisition, consolidation and retention of newly acquired behavior in rats \[[@CR10]\]. Subsequent studies demonstrate that these compounds significantly attenuated the phenytoin \[[@CR11]\], diazepam \[[@CR12]\], hypobaric hypoxia \[[@CR13]\], L-NNA \[[@CR14]\], scopolamine \[[@CR15]\], *m*CPBG \[[@CR16]\] and [d]{.smallcaps}-galactose \[[@CR17]\] induced memory impairments in rats. *B. monniera* treatment modulates various neurotransmitters such as acetylcholine (ACh), serotonin (5-hydroxytryptamine, 5-HT), gamma amino butyric acid (GABA), glutamate (Glu) and dopamine (DA) at different brain regions to enhance the cognitive functions \[[@CR16], [@CR18]--[@CR24]\].

It has been documented that variations in serotonin metabolism and transmission is often associated with changes in short and long-term memory \[[@CR25]--[@CR28]\]. Biosynthesis of serotonin is regulated by the rate-limiting enzyme tryptophan hydroxylase (TPH) (EC. 1. 14. 16. 4), which converts [l]{.smallcaps}-tryptophan to 5-hydroxy-[l]{.smallcaps}-tryptophan using molecular oxygen, non-heme iron (II) with tetrahydrobiopterin (BH~4~) as a cofactor \[[@CR29], [@CR30]\]. There are two forms of TPH; TPH1 is responsible for most peripheral 5-HT, whereas, TPH2 is neuronal specific \[[@CR31]--[@CR34]\]. Isoforms of TPH (TPH1, TPH2) are highly homologous with an identity of 68--71 % across the phyla, and possess similar three-dimensional structure with respect to the location of amino acid residues where the substrate binds or the active site geometry \[[@CR35]\]. TPH2 holds different kinetic properties like higher specificity for [l]{.smallcaps}-tryptophan but a lower catalytic efficiency. It has higher molecular weight than TPH1 because of the elongated N-terminal domain (approx. 56 kDa compared to TPH1 which is 51 kDa) and also possess an additional phosphorylation site \[[@CR36]\]. Studies indicate that up-regulation of TPH expression leads to an enhancement of TPH activity and 5-HT synthesis \[[@CR37], [@CR38]\].

Recently, we found that the administration of *B. monniera* leaf extract in postnatal rats elevates the 5-HT level by up-regulating tryptophan hydroxylase-2 (TPH2) and serotonin transporter (SERT) expression \[[@CR24]\]. Thus the elevated 5-HT level influences learning and memory by modulating other ACh and Glu, acting through the 5-HT~3~ receptor \[[@CR16]\]. The structure of TPH with Fe and its cofactor BH~2~ complex have been documented \[[@CR39]\]. However, the interaction between bacoside A and TPH was not studied yet. Based on the limitations, as a first attempt we adopted in silico approach to study the complex interactions. At this point, we used three different automatic molecular docking algorithms such as AutoDock, PatchDock and HexDock to identify interactions between the complexes. Through various interactions, molecular recognition occurs between protein and ligand, which is critical for identifying binding partners to the binding site. Our in silico study showed the interaction of bacosides (A~3~, A) with TPH, which is believed to be involved in the up-regulation of 5-HT synthesis.

Results and Discussion {#Sec2}
======================

To uncover the structural basis of docking interactions between TPH and bacosides, we sought to determine the complex formation. Number of active compounds was identified for therapeutic targets based on the binding of ligand with protein, in which virtual screening and computational tools plays a major role \[[@CR40], [@CR41]\]. Bacosides are non-polar glycosides; lipid-mediated transportation by passive diffusion may facilitate transport across blood--brain barrier \[[@CR8], [@CR9], [@CR42]\] and interact with TPH2. The general 3D molecular structure with combination of bacoside-TPH showed that the bioactive compounds present in the *B. monniera* leaf extract interact with TPH, which may up-regulate TPH2 expression \[[@CR24]\]. In our study, we tested bacoside-TPH interactions in three different algorithms developed based on combinations of various scoring functions. This would help us to identify the true hits and reduce the errors \[[@CR43]\]. After finding its interactions with bacoside A and A~3~, we have found out that both plugs into a hydrophobic pocket of TPH. Further, our analysis showed that all the three docking algorithms identified similar residues (Tyr235, Thr265, Pro268, His272, Glu317, Phe318, Ser337, Glu340, Ile 366) surrounding (within 3.0 Å) bacoside A as best hit and interacts with different residues of TPH. However, HexDock and PatchDock (Fig. [1](#Fig1){ref-type="fig"}b) identified that Thr265 (1.46 and 1.91 Å) is the residue involved in hydrogen bond, where as AutoDock identified Glu 317 (1.79 Å) as an interacting residue (Fig. [1](#Fig1){ref-type="fig"}). Bacoside A -- TPH complex showed docking score of 5002 with atomic contact energy −291.73. In addition, the estimated free energy for the complex is −9.29 kcal/mol with an inhibition constant (Ki) of 156.17 nM. Similarly, all the three docking algorithms showed Tyr235, Thr265, Pro268, Glu317, Ser337 and Cys364 residues (within 3.0 Å) in the pocket of the TPH surrounding bacoside A~3~. Among them all the three docking algorithm identified different residues Thr265 (1.91 Å) (Fig. [2](#Fig2){ref-type="fig"}a), Tyr235 (2.96 Å) (Fig. [2](#Fig2){ref-type="fig"}b) and Glu317 (2.48 Å) (Fig. [2](#Fig2){ref-type="fig"}c) interacting with bacoside A~3~ through hydrogen bond. Bacoside A~3~ with TPH complex showed docking score of 5472 with atomic contact energy −424.37. Further, we noted −10.23 kcal/mol as a estimated free energy for bacoside A~3~-TPH complex with the Ki of 37.36 nM.Fig. 13D molecular structure from combination of TPH and bacoside A generated using HexDock (**a**), PatchDock (**b**) and AutoDock (**c**) showing the interactions with key residuesFig. 2TPH and bacoside A complex 3D molecular structure generated using HexDoc (**a**), PatchDock (**b**) and AutoDock (**c**) showing the interactions with key residues Thr265, Tyr235 and Glu317 respectively

In the present study, our in silico analysis showed that bacosides (A~3~, A) interact with TPH. We found that the bacoside A~3~ showed higher interaction score when compared to the interaction of bacoside A with TPH. The bioactive compounds: bacoside A and A~3~ formed hydrogen bond with TPH at two key residues Glu317 and Tyr235. Its note worthy to mention that tryptophan binds with Leu124-Asp139 and Ile367-Thr369 loop regions of TPH which are involved in conformational change \[[@CR44], [@CR45]\]. Interestingly, except Glu317 (O of Glu317 with H- of bacosides), the bacosides binding amino acids were not present at either the tryptophan or the co-factor BH4 (Gly 234, Leu 236, His 251, Glu 273, Glu 317) binding sites \[[@CR44], [@CR45]\]. In fact, we found that bacoside A~3~ and A formed hydrogen bond with Glu317. Although Glu317 of TPH bound with Fe, it also interacts with bacoside A~3~/A at a different side chain. Notably, bacoside A, A~3~ interact with Thr265, which is in the line of active site channel of TPH (residue 263--269 and 363--372) having high B-factor and less electron density \[[@CR39]\]. It appears that these regions are highly flexible and the interaction at this site might enhance the TPH activity, possibly the reason for the observed elevated level of TPH activity \[[@CR24]\]. Further, our analysis showed that bacoside A~3~ interacts with Tyr235 of TPH, which is conserved in all known TPH. Specific mutants of Tyr235 increase the *Km* for substrate ([l]{.smallcaps}-Trp) and lower *Km* for cofactor (BH4) \[[@CR46]\]. These interactions add additional insight into the function of bacoside in 5-HT synthesis.

Conclusion {#Sec3}
==========

Our in silico analysis showed that the bacosides (A~3~, A)-TPH complex interact through hydrogen bond with specific sites. These specific sites are known to regulate the catalytic mechanism of TPH \[[@CR44]--[@CR46]\], bacosides interactions may facilitate TPH activity and thus enhance the synthesis of serotonin \[[@CR24]\]. Further study in bacosides interaction with different mutated TPH may provide greater insight in understanding the effect of bacosides in serotonergic system for the potential applications.

General Experimental Procedures {#Sec4}
===============================

The PDB format of TPH enzyme (PDB ID: 1MLW) was retrieved from protein data bank. Likewise, the chemical structures of bioactive compounds Bacoside A (Compound ID: 53398644), Bacoside A~3~ (Compound ID: 44152167) were collected from database (<http://pubchem.ncbi.nlm.nih.gov>) and then converted as protein data using OpenBabel \[[@CR47]\] and docked with TPH. Different algorithms such as AutoDock \[[@CR48]\], PatchDock \[[@CR49]\] and HexDock \[[@CR50]\] was used based on complementary shape principles matching two molecules by searching complementary to each other. Any type molecules (proteins, DNA, peptides, drugs) can be docked in PatchDock. A wide interface is ensured to include several matched local features of the docked molecules that have complementary characteristics. The molecules detected as concave are matched with convex and flat patches. Then the candidate transformation generated by patched with complementary patches. Each candidate transformation is further evaluated by a scoring function that considers both geometric fit and atomic desolvation energy. Finally, an RMSD (root mean square deviation) clustering is applied to the candidate solutions to discard redundant solutions \[[@CR40]\]. The remaining matched candidates are ranked according to the geometric shape complementarity score. The generated TPH and bacoside three-dimension (3D) molecule complex was further analyzed by the Swiss-pdb viewer (ver 4.1). An algorithm has been used to identify the hydrophobic and hydrogen bond interaction, based on the distance between ligand--protein atoms, which is below 3.0 Å \[[@CR51]\].
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